Novavax’s Vaccine Works Well — Except on Variant First Found in South Africa
Health
By BY KATIE THOMAS, CARL ZIMMER AND SHARON LAFRANIERE from NYT Health https://ift.tt/3t04Lwl
via IFTTT Vaccination and Immunization, Clinical Trials, Coronavirus (2019-nCoV), your-feed-science An early analysis in Britain found that the vaccine had an efficacy rate of nearly 90 percent. But in a small South Africa trial, the efficacy rate dropped to just under 50 percent.

By BY KATIE THOMAS, CARL ZIMMER AND SHARON LAFRANIERE from NYT Health https://ift.tt/3t04Lwl
via IFTTT Vaccination and Immunization, Clinical Trials, Coronavirus (2019-nCoV), your-feed-science An early analysis in Britain found that the vaccine had an efficacy rate of nearly 90 percent. But in a small South Africa trial, the efficacy rate dropped to just under 50 percent.
Comments
Post a Comment